Copyright Reports & Markets. All rights reserved.

Global Intravenous Immune Globulin Therapies Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Liquid Form
      • 1.4.3 Lyophilized Powder Form
    • 1.5 Market by Application
      • 1.5.1 Global Intravenous Immune Globulin Therapies Market Share by Application (2014-2025)
      • 1.5.2 Immunodeficiency
      • 1.5.3 Autoimmune Disease
      • 1.5.4 Acute Infection
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Intravenous Immune Globulin Therapies Market Size
    • 2.2 Intravenous Immune Globulin Therapies Growth Trends by Regions
      • 2.2.1 Intravenous Immune Globulin Therapies Market Size by Regions (2014-2025)
      • 2.2.2 Intravenous Immune Globulin Therapies Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Intravenous Immune Globulin Therapies Market Size by Manufacturers
      • 3.1.1 Global Intravenous Immune Globulin Therapies Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Intravenous Immune Globulin Therapies Market Concentration Ratio (CR5 and HHI)
    • 3.2 Intravenous Immune Globulin Therapies Key Players Head office and Area Served
    • 3.3 Key Players Intravenous Immune Globulin Therapies Product/Solution/Service
    • 3.4 Date of Enter into Intravenous Immune Globulin Therapies Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Intravenous Immune Globulin Therapies Market Size by Type (2014-2019)
    • 4.2 Global Intravenous Immune Globulin Therapies Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Intravenous Immune Globulin Therapies Market Size (2014-2019)
    • 5.2 Intravenous Immune Globulin Therapies Key Players in United States
    • 5.3 United States Intravenous Immune Globulin Therapies Market Size by Type
    • 5.4 United States Intravenous Immune Globulin Therapies Market Size by Application

    6 Europe

    • 6.1 Europe Intravenous Immune Globulin Therapies Market Size (2014-2019)
    • 6.2 Intravenous Immune Globulin Therapies Key Players in Europe
    • 6.3 Europe Intravenous Immune Globulin Therapies Market Size by Type
    • 6.4 Europe Intravenous Immune Globulin Therapies Market Size by Application

    7 China

    • 7.1 China Intravenous Immune Globulin Therapies Market Size (2014-2019)
    • 7.2 Intravenous Immune Globulin Therapies Key Players in China
    • 7.3 China Intravenous Immune Globulin Therapies Market Size by Type
    • 7.4 China Intravenous Immune Globulin Therapies Market Size by Application

    8 Japan

    • 8.1 Japan Intravenous Immune Globulin Therapies Market Size (2014-2019)
    • 8.2 Intravenous Immune Globulin Therapies Key Players in Japan
    • 8.3 Japan Intravenous Immune Globulin Therapies Market Size by Type
    • 8.4 Japan Intravenous Immune Globulin Therapies Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Intravenous Immune Globulin Therapies Market Size (2014-2019)
    • 9.2 Intravenous Immune Globulin Therapies Key Players in Southeast Asia
    • 9.3 Southeast Asia Intravenous Immune Globulin Therapies Market Size by Type
    • 9.4 Southeast Asia Intravenous Immune Globulin Therapies Market Size by Application

    10 India

    • 10.1 India Intravenous Immune Globulin Therapies Market Size (2014-2019)
    • 10.2 Intravenous Immune Globulin Therapies Key Players in India
    • 10.3 India Intravenous Immune Globulin Therapies Market Size by Type
    • 10.4 India Intravenous Immune Globulin Therapies Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Intravenous Immune Globulin Therapies Market Size (2014-2019)
    • 11.2 Intravenous Immune Globulin Therapies Key Players in Central & South America
    • 11.3 Central & South America Intravenous Immune Globulin Therapies Market Size by Type
    • 11.4 Central & South America Intravenous Immune Globulin Therapies Market Size by Application

    12 International Players Profiles

    • 12.1 Baxter
      • 12.1.1 Baxter Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Intravenous Immune Globulin Therapies Introduction
      • 12.1.4 Baxter Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
      • 12.1.5 Baxter Recent Development
    • 12.2 Grifols
      • 12.2.1 Grifols Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Intravenous Immune Globulin Therapies Introduction
      • 12.2.4 Grifols Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
      • 12.2.5 Grifols Recent Development
    • 12.3 CSL Plasma
      • 12.3.1 CSL Plasma Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Intravenous Immune Globulin Therapies Introduction
      • 12.3.4 CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
      • 12.3.5 CSL Plasma Recent Development
    • 12.4 Octapharma
      • 12.4.1 Octapharma Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Intravenous Immune Globulin Therapies Introduction
      • 12.4.4 Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
      • 12.4.5 Octapharma Recent Development
    • 12.5 Biotest
      • 12.5.1 Biotest Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Intravenous Immune Globulin Therapies Introduction
      • 12.5.4 Biotest Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
      • 12.5.5 Biotest Recent Development
    • 12.6 Kedrion
      • 12.6.1 Kedrion Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Intravenous Immune Globulin Therapies Introduction
      • 12.6.4 Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
      • 12.6.5 Kedrion Recent Development
    • 12.7 Kamada
      • 12.7.1 Kamada Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Intravenous Immune Globulin Therapies Introduction
      • 12.7.4 Kamada Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
      • 12.7.5 Kamada Recent Development
    • 12.8 China Biologic Products Holdings
      • 12.8.1 China Biologic Products Holdings Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Intravenous Immune Globulin Therapies Introduction
      • 12.8.4 China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
      • 12.8.5 China Biologic Products Holdings Recent Development
    • 12.9 Hualan Biological Engineering
      • 12.9.1 Hualan Biological Engineering Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Intravenous Immune Globulin Therapies Introduction
      • 12.9.4 Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
      • 12.9.5 Hualan Biological Engineering Recent Development
    • 12.10 Sichuan Yuanda Shuyang Pharmaceutical
      • 12.10.1 Sichuan Yuanda Shuyang Pharmaceutical Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Intravenous Immune Globulin Therapies Introduction
      • 12.10.4 Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
      • 12.10.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.
      In 2018, the global Intravenous Immune Globulin Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Intravenous Immune Globulin Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Intravenous Immune Globulin Therapies development in United States, Europe and China.

      The key players covered in this study
      Baxter
      Grifols
      CSL Plasma
      Octapharma
      Biotest
      Kedrion
      Kamada
      China Biologic Products Holdings
      Hualan Biological Engineering
      Sichuan Yuanda Shuyang Pharmaceutical

      Market segment by Type, the product can be split into
      Liquid Form
      Lyophilized Powder Form

      Market segment by Application, split into
      Immunodeficiency
      Autoimmune Disease
      Acute Infection

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Intravenous Immune Globulin Therapies status, future forecast, growth opportunity, key market and key players.
      To present the Intravenous Immune Globulin Therapies development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Intravenous Immune Globulin Therapies are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now